Related Experiment Video
Updated: Jan 26, 2026

Feeder-free Derivation of Neural Crest Progenitor Cells from Human Pluripotent Stem Cells
Published on: May 22, 2014
Engraftment of Human Stem Cell-Derived Otic Progenitors in the Damaged Cochlea
Alejandra Lopez-Juarez1, Hanae Lahlou2, Chantal Ripoll3
1CNRS UMR 7260, Aix-Marseille Université, Marseille, France; Chemical, Electronic and Biomedical Engineering, Universidad de Guanajuato, Guanajuato, Mexico.
Abstract:
Most cases of sensorineural deafness are caused by degeneration of hair cells. Although stem/progenitor cell therapy is becoming a promising treatment strategy in a variety of organ systems, cell engraftment in the adult mammalian cochlea has not yet been demonstrated. In this study, we generated human otic progenitor cells (hOPCs) from induced pluripotent stem cells (iPSCs) in vitro and identified these cells by the expression of known otic markers. We showed successful cell transplantation of iPSC-derived-hOPCs in an in vivo adult guinea pig model of ototoxicity. The delivered hOPCs migrated throughout the cochlea, engrafted in non-sensory regions, and survived up to 4 weeks post-transplantation. Some of the engrafted hOPCs responded to environmental cues within the cochlear sensory epithelium and displayed molecular features of early sensory differentiation. We confirmed these results with hair cell progenitors derived from Atoh1-GFP mice as donor cells. These mouse otic progenitors transplanted using the same in vivo delivery system migrated into damaged cochlear sensory epithelium and adopted a partial sensory cell fate. This is the first report of the survival and differentiation of hOPCs in ototoxic-injured mature cochlear epithelium, and it should stimulate further research into cell-based therapies for treatment of deafness.
Insights
Human otic progenitor cells (hOPCs) derived from induced pluripotent stem cells (iPSCs) successfully engrafted and survived in a guinea pig model of sensorineural deafness. These cells showed potential for sensory differentiation, offering hope for new hearing loss treatments.
Area of Science:
- Regenerative Medicine
- Otolaryngology
- Stem Cell Biology
Background:
- Sensorineural deafness often results from hair cell degeneration.
- Stem cell therapy shows promise for organ regeneration, but cochlear engraftment remains unproven.
- Developing effective cell-based treatments for hearing loss requires demonstrating successful cell survival and integration in the cochlea.
Purpose of the Study:
- To generate human otic progenitor cells (hOPCs) from induced pluripotent stem cells (iPSCs).
- To assess the in vivo survival, migration, and differentiation potential of iPSC-derived hOPCs in an adult mammalian cochlea.
- To establish proof-of-concept for stem cell therapy in treating sensorineural deafness.
Main Methods:
- Generated hOPCs from iPSCs in vitro, identified by otic markers.
- Transplanted iPSC-derived hOPCs into an adult guinea pig model of ototoxicity.
- Utilized Atoh1-GFP mouse hair cell progenitors to confirm findings in a similar delivery system.
Main Results:
- Transplanted hOPCs successfully engrafted in non-sensory cochlear regions and survived for up to 4 weeks.
- Engrafted hOPCs responded to cochlear environmental cues, exhibiting early sensory differentiation markers.
- Mouse otic progenitors also migrated into damaged cochlear epithelium and adopted partial sensory cell fates.
Conclusions:
- This study demonstrates the first successful survival and differentiation of human otic progenitor cells in an injured mature cochlear environment.
- These findings support the potential of iPSC-derived hOPCs for cell-based therapies aimed at treating sensorineural deafness.
- Further research into stem cell therapies is warranted to advance treatments for hearing loss.
More Related Videos
Related Concept Videos
The Cochlea
Embryonic Stem Cells
Induced Pluripotent Stem Cells
Adult Stem Cells
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

